Exciting developments in gene therapy for Huntington's are on the horizon, with several studies currently in human trials focusing on safety and feasibility. The potential for using CRISPR technology offers hope for those affected by the disease. Acknowledgment is given to valuable sources that provide historical context and future perspectives on neurodegeneration therapies.
